The global cardiac surgery instruments market size was estimated at USD 2.99 Billion in 2025 and is projected to reach USD 5.36 billion, growing at a CAGR of 7.56% from 2025 to 2033. Rising prevalence of cardiovascular diseases, increasing adoption of advanced surgical techniques, and growing demand for precision-driven procedures are expected to drive the cardiac surgery instruments market.
The shift toward minimally invasive surgeries, coupled with technological advancements that enhance safety and efficiency, is further anticipated to support market expansion. In August 2025, the European Journal of Preventive Cardiology reported that global CVD prevalence will rise 90% by 2050, with deaths increasing from 20.5 million in 2025 to 35.6 million, while age-standardized mortality is projected to fall 30.5%. The rising prevalence of cardiovascular diseases is a primary driver for the cardiac surgery instruments market, as these conditions remain the leading cause of mortality worldwide and frequently necessitate surgical intervention. With aging populations and growing incidence of lifestyle-related disorders such as obesity, hypertension, and diabetes, the number of patients requiring procedures like coronary artery bypass grafting and valve repair continues to rise. In July 2025, the World Health Organization (WHO) reported that cardiovascular diseases caused 19.8 million deaths in 2022 (32% of all deaths), with 85% from heart attack and stroke, and over three-quarters occurring in low- and middle-income countries.
The increasing adoption of advanced surgical techniques, including minimally invasive and robotic-assisted procedures, is fueling the need for specialized instruments designed for precision and efficiency. Surgeons and hospitals are shifting away from traditional open-heart approaches toward less invasive methods that require advanced toolkits with ergonomic designs, durability, and compatibility with hybrid operating rooms. In July 2022, Netcare Christiaan Barnard Hospital in South Africa introduced the first robotic-assisted cardiothoracic surgery program in the region using the da Vinci system. These techniques improve surgical accuracy and reduce recovery times, making them highly preferred by both healthcare providers and patients, thereby accelerating the demand for next-generation cardiac surgery instruments.
Growing demand for precision-driven procedures also plays a significant role in market expansion, as cardiac surgeries require exactness where even the smallest errors can have life-threatening consequences. The push for accuracy has led to innovations in instrument design, with micro-instruments, enhanced forceps, and sharper cutting tools becoming essential in complex surgeries such as pediatric and valve procedures. In May 2025, an article in the Annals of Cardiothoracic Surgery highlighted the adoption of fully robotic lateral access aortic valve replacement (RAVR) as a key advancement in minimally invasive surgery. The procedure demands high-precision handling, making forceps integral for tissue manipulation and suturing in confined operative fields.
The growing prevalence of cardiovascular diseases, combined with the expansion of cardiac surgical procedures worldwide, is driving steady demand for advanced cardiac surgery instruments. Hospitals and surgical centers are increasingly investing in high-quality tools to improve patient outcomes, reduce procedure times, and support minimally invasive techniques, highlighting the critical role of reliable instruments in modern cardiac care. Rising awareness of cardiovascular health and increasing healthcare infrastructure in emerging markets are further boosting demand, while innovations in instrument design continue to enhance surgical precision and safety.
In June 2024, an article in Annals of Thoracic Surgery Short Reports highlighted that high-income countries perform an average of 123.2 cardiac surgeries per 100,000 population annually, while low- and middle-income countries perform 40-86 procedures per 100,000, reflecting a substantial global gap. With over 1 million cardiac surgeries worldwide each year, including CABG, valve, and congenital procedures, the study underscores the growing demand for cardiac surgery instruments to meet population needs. Expanding surgical capacity in LMICs could significantly increase procedure volumes, driving demand for specialized instruments.
This product will be delivered within 1-3 business days.
The shift toward minimally invasive surgeries, coupled with technological advancements that enhance safety and efficiency, is further anticipated to support market expansion. In August 2025, the European Journal of Preventive Cardiology reported that global CVD prevalence will rise 90% by 2050, with deaths increasing from 20.5 million in 2025 to 35.6 million, while age-standardized mortality is projected to fall 30.5%. The rising prevalence of cardiovascular diseases is a primary driver for the cardiac surgery instruments market, as these conditions remain the leading cause of mortality worldwide and frequently necessitate surgical intervention. With aging populations and growing incidence of lifestyle-related disorders such as obesity, hypertension, and diabetes, the number of patients requiring procedures like coronary artery bypass grafting and valve repair continues to rise. In July 2025, the World Health Organization (WHO) reported that cardiovascular diseases caused 19.8 million deaths in 2022 (32% of all deaths), with 85% from heart attack and stroke, and over three-quarters occurring in low- and middle-income countries.
The increasing adoption of advanced surgical techniques, including minimally invasive and robotic-assisted procedures, is fueling the need for specialized instruments designed for precision and efficiency. Surgeons and hospitals are shifting away from traditional open-heart approaches toward less invasive methods that require advanced toolkits with ergonomic designs, durability, and compatibility with hybrid operating rooms. In July 2022, Netcare Christiaan Barnard Hospital in South Africa introduced the first robotic-assisted cardiothoracic surgery program in the region using the da Vinci system. These techniques improve surgical accuracy and reduce recovery times, making them highly preferred by both healthcare providers and patients, thereby accelerating the demand for next-generation cardiac surgery instruments.
Growing demand for precision-driven procedures also plays a significant role in market expansion, as cardiac surgeries require exactness where even the smallest errors can have life-threatening consequences. The push for accuracy has led to innovations in instrument design, with micro-instruments, enhanced forceps, and sharper cutting tools becoming essential in complex surgeries such as pediatric and valve procedures. In May 2025, an article in the Annals of Cardiothoracic Surgery highlighted the adoption of fully robotic lateral access aortic valve replacement (RAVR) as a key advancement in minimally invasive surgery. The procedure demands high-precision handling, making forceps integral for tissue manipulation and suturing in confined operative fields.
The growing prevalence of cardiovascular diseases, combined with the expansion of cardiac surgical procedures worldwide, is driving steady demand for advanced cardiac surgery instruments. Hospitals and surgical centers are increasingly investing in high-quality tools to improve patient outcomes, reduce procedure times, and support minimally invasive techniques, highlighting the critical role of reliable instruments in modern cardiac care. Rising awareness of cardiovascular health and increasing healthcare infrastructure in emerging markets are further boosting demand, while innovations in instrument design continue to enhance surgical precision and safety.
In June 2024, an article in Annals of Thoracic Surgery Short Reports highlighted that high-income countries perform an average of 123.2 cardiac surgeries per 100,000 population annually, while low- and middle-income countries perform 40-86 procedures per 100,000, reflecting a substantial global gap. With over 1 million cardiac surgeries worldwide each year, including CABG, valve, and congenital procedures, the study underscores the growing demand for cardiac surgery instruments to meet population needs. Expanding surgical capacity in LMICs could significantly increase procedure volumes, driving demand for specialized instruments.
Global Cardiac Surgery Instruments Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global cardiac surgery instruments market report based on product, application, end use, and region:- Product Outlook (Revenue USD Million, 2021-2033)
- Forceps
- Clamps
- Graspers
- Scissors
- Needle Holder
- Others
- Application Outlook (Revenue USD Million, 2021-2033)
- Coronary Artery Bypass Grafting
- Heart Valve Surgery
- Pediatric Cardiac Surgery
- Heart Transplant
- Others
- End Use Outlook (Revenue USD Million, 2021-2033)
- Hospitals
- Ambulatory Surgical Center
- Regional Outlook (Revenue USD Million, 2021-2033)
- North America
- Europe
- Asia-Pacific
- Latin America
- MEA
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Cardiac Surgery Instruments Market Variables, Trends & Scope
Chapter 4. Cardiac Surgery Instruments Market Segment Analysis, by Product, 2021-2033 (USD Million)
Chapter 5. Cardiac Surgery Instruments Market Segment Analysis, by Application, 2021-2033 (USD Million)
Chapter 6. Cardiac Surgery Instruments Market Segment Analysis, by End Use, 2021-2033 (USD Million)
Chapter 7. Cardiac Surgery Instruments Market Segment Analysis, by Region, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The leading players profiled in this Cardiac Surgery Instruments market report include:- . Braun Melsungen AG
- LS Martin Group.
- eleflex Incorporated
- edline Industries, Inc.
- TILLE
- klar Corporation
- exler Surgical
- urray Surgical
- urtex Instruments Limited
- canlan International
- elacroix-Chevailer
- D
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | September 2025 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 2.99 Billion |
| Forecasted Market Value ( USD | $ 5.36 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
